Which of the following oral diabetes treatments are associated with high risks of hypoglycemia?

DPP-4 inhibitors (like Sitagliptin)

GLP-1 receptor agonist (like exanitide)

SGLT-2 Inhibitors (like Dapaglifozin)

Sulfonylureas (like Glipizide)